Cargando…

MET Receptor Tyrosine Kinase Inhibition Reduces Interferon-Gamma (IFN-γ)-Stimulated PD-L1 Expression through the STAT3 Pathway in Melanoma Cells

SIMPLE SUMMARY: While the treatment of melanoma was revolutionized about a decade ago by the introduction of immunotherapies and targeted therapies, advanced melanoma remains a therapeutic challenge. Here we demonstrate a cross-talk between a checkpoint protein, PD-L1, and a receptor tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Kyu Young, Han, Yong Hwan, Roehrich, Heidi, Brown, Mary E., Torres-Cabala, Carlos, Giubellino, Alessio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340457/ https://www.ncbi.nlm.nih.gov/pubmed/37444518 http://dx.doi.org/10.3390/cancers15133408

Ejemplares similares

Correlation of MET and PD-L1 Expression in Malignant Melanoma
por: Song, Kyu Young, et al.
Publicado: (2020)

Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant Melanoma
por: Koo, Karen, et al.
Publicado: (2023)

Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours
por: Martin, Valentina, et al.
Publicado: (2019)

High levels of interferon-gamma (IFNγ) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFNγ production in MAS
por: Bracaglia, C, et al.
Publicado: (2015)

Blockade Effects of Anti-Interferon- (IFN-) γ Autoantibodies on IFN-γ-Regulated Antimicrobial Immunity
por: Krisnawati, Dyah Ika, et al.
Publicado: (2019)

Editorial for Special Issue “Molecular Mechanisms and Signaling Pathways in Melanoma”
por: Giubellino, Alessio, et al.
Publicado: (2023)

Interferon gamma (IFN-γ) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription
por: Li, Ping, et al.
Publicado: (2012)

Interferon gamma (IFNγ) +874A/T gene polymorphism in South Indian ischemic stroke patients
por: Sultana, Shehnaz, et al.
Publicado: (2011)

Serum Concentrations of Interferon Gamma (IFN-γ) in Patients with Psoriasis: Correlation with Clinical Type and Severity of the Disease
por: Kurtovic, Nermina Ovcina, et al.
Publicado: (2018)

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
por: Thiem, Alexander, et al.
Publicado: (2019)

MACC1 and MET as markers associated with progression and metastasis in cutaneous melanoma
por: Zhou, Yan, et al.
Publicado: (2023)

Immunoproteasome Assembly: Cooperative Incorporation of Interferon γ (IFN-γ)–inducible Subunits
por: Griffin, Thomas A., et al.
Publicado: (1998)

Interferon gamma (IFN-γ)-mediated inflammation and the kynurenine pathway in relation to risk of hip fractures: the Hordaland Health Study
por: Apalset, E. M., et al.
Publicado: (2014)

Interferon-Gamma (IFN-γ)-Mediated Retinal Ganglion Cell Death in Human Tyrosinase T Cell Receptor Transgenic Mouse
por: Husain, Shahid, et al.
Publicado: (2014)

Immunization of mice with soluble lysate of interferon gamma expressing Plasmodium berghei ANKA induces high IFN-γ production
por: Taylor, Ebenezer, et al.
Publicado: (2017)

PD-L1 upregulation by IFN-α/γ-mediated Stat1 suppresses anti-HBV T cell response
por: Liu, LanLan, et al.
Publicado: (2020)

Direct AKT activation in tumor-infiltrating lymphocytes markedly increases interferon-γ (IFN-γ) for the regression of tumors resistant to PD-1 checkpoint blockade
por: Santinon, François, et al.
Publicado: (2022)

Identification of risk factors associated with disclosure of false positive bovine tuberculosis reactors using the gamma-interferon (IFNγ) assay
por: Gormley, Eamonn, et al.
Publicado: (2013)

Tyrosine Kinase Inhibitors Stimulate HLA Class I Expression by Augmenting the IFNγ/STAT1 Signaling in Hepatocellular Carcinoma Cells
por: Takahashi, Aya, et al.
Publicado: (2021)

Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS
por: Yoyen-Ermis, Digdem, et al.
Publicado: (2019)

PD‐L1 expression is mainly regulated by interferon gamma associated with JAK‐STAT pathway in gastric cancer
por: Mimura, Kousaku, et al.
Publicado: (2017)

A secondary role for hypoxia and HIF1 in the regulation of (IFNγ-induced) PD-L1 expression in melanoma
por: van Duijn, Anneloes, et al.
Publicado: (2021)

Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma
por: Demkova, Lucia, et al.
Publicado: (2018)

Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma
por: Cui, Chuanliang, et al.
Publicado: (2021)

Anti interferon-gamma (IFNγ) monoclonal antibody treatment in a patient carrying an NLRC4 mutation and severe hemophagocytic lymphohistiocytosis
por: Bracaglia, C, et al.
Publicado: (2015)

Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes
por: Mehta, Sunali Y., et al.
Publicado: (2018)

Interferon gamma (IFN-γ) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens
por: Nakiboneka, Ritah, et al.
Publicado: (2019)

Mouse Gamma Herpesvirus MHV-68 Induces Severe Gastrointestinal (GI) Dilatation in Interferon Gamma Receptor-Deficient Mice (IFNγR(−/−)) That Is Blocked by Interleukin-10
por: Chen, Hao, et al.
Publicado: (2018)

Salt suppresses IFNγ inducible chemokines through the IFNγ-JAK1-STAT1 signaling pathway in proximal tubular cells
por: Arai, Yohei, et al.
Publicado: (2017)

IL-11 prevents IFN-γ-induced hepatocyte death through selective downregulation of IFN-γ/STAT1 signaling and ROS scavenging
por: Miyawaki, Akimitsu, et al.
Publicado: (2019)

Anti-PD1 up-regulates PD-L1 expression and inhibits T-cell lymphoma progression: possible involvement of an IFN-γ-associated JAK-STAT pathway
por: Xue, Weili, et al.
Publicado: (2019)

Interferon (IFNγ) induces cell cycle arrest in RCC cell lines
por: Tate, David J, et al.
Publicado: (2013)

Dynamical modelling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity
por: Subhadarshini, Seemadri, et al.
Publicado: (2023)

Dynamical modeling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity
por: Subhadarshini, Seemadri, et al.
Publicado: (2023)

Polymorphisms within the Promoter Region of the Gamma Interferon (IFN-γ) Receptor1 Gene are Associated with the Susceptibility to Chronic HBV Infection in an Iranian Population
por: Khanizadeh, Sayyad, et al.
Publicado: (2012)

NGS Evaluation of Colorectal Cancer Reveals Interferon Gamma Dependent Expression of Immune Checkpoint Genes and Identification of Novel IFNγ Induced Genes
por: Xu, Lai, et al.
Publicado: (2020)

Lac water extract inhibits IFN-γ signaling through JAK2-STAT1-IRF1 axis in human melanoma
por: Li, Luhui, et al.
Publicado: (2018)

IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma
por: Moon, Ji Wook, et al.
Publicado: (2017)

IFNγ score–based neoadjuvant immunotherapy for stage III melanoma
por: Fukuda, Keitaro
Publicado: (2023)

ERK is a negative feedback regulator for IFN-γ/STAT1 signaling by promoting STAT1 ubiquitination
por: Zhang, Ying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d8b90nb2pj8h1cmfuq2t0p476e